India's Shasun Move Into Japan Signals Changing Attitudes Toward API Makers

Japanese drug makers are the target of a major effort by India's Shasun Chemicals and Drugs to have a large presence as a supplier of active pharmaceutical ingredients. Shasun is a leading producer of APIs and intermediaries and the world's leading maker of ibuprofen. The firm is a major supplier to leading Western drug makers, but has not had much of a presence in Japan because its pharmas tended not to outsource such work. The economic climate is leading many Japanese firms to rethink that policy as a way to cut costs. (Click here for more - a subscription may be required